Ryan Haumschild, PharmD, MS, MBA, drives an expert discussion focused on challenges associated with clinical pathway utilization in treating patients with HCC. The panel discussion focused on the ...

Dynamic clinical pathways are essential to keep pace with rapid advancements in oncology treatments and FDA approvals. Inclusive participation and effective communication are vital for pathway ...

Phase II Clinical Study of Adebrelimab and Bevacizumab Combined With Cisplatin/Carboplatin in Patients With Triple-Negative Breast Cancer With Brain Metastases (ABC Study) Receipt of previous ...

Researchers have developed a three-step plan to support those burdened by the intense fear of cancer returning. This plan offers a consistent, streamlined approach to managing recurrence anxiety, ...

More hospitals and health systems should be focusing on developing evidence-based clinical pathways as part of broader efforts to free up capacity and improve operational efficiency, according to ...

Baringa’s Kate Moss co-led a workshop with Sanofi's Vicky DiBiaso, VP Global Head Patient Informed Development & Health Value Translation, and patient advocate and author Alfred Samuels. The workshop ...

The 10-year anniversary meeting, November 10-11 in Boston, returns to CPC’s roots—uniting decision-makers on execution, evidence, and sustainable care delivery. CPC returns to its roots this year as a ...

BEIJING, April 7, 2026 /PRNewswire/ -- Singlomics Biopharmaceuticals, an innovative clinical-stage biopharmaceutical company focused on the discovery and development of antibody therapeutics for ...

Pasithea Therapeutics Corp. has announced the successful enrollment and initial dosing of three subjects in Cohort 6 of its Phase 1 clinical trial for PAS-004, a candidate for treating ...

Medicus Pharma reports over 50% patient enrollment in Phase 2 study for basal cell carcinoma treatment, aiming for FDA fast-track approval. Medicus Pharma Ltd. announced that over 50% of the 60 ...